Today’s clinical development and regulatory environment requires biopharma companies to be agile and forward thinking in order to continuously optimize their operating models. As a critical part of Syneos Health Consulting, our R&D Advisory Group helps biopharma companies of all sizes focus on designing, planning and implementing large scale organizational changes that address their specific needs.
Our R&D Advisory Group was built from the Syneos Health acquisition of Kinapse, an industry-leading consultancy with deep expertise in R&D organizational, process and technology-enabled transformations. We blend industry-leading consulting expertise with recognized experts across the entire spectrum of research and development. Our delivery teams combine consulting with hands-on subject matter experts to bring deep insights to our R&D advisory services. Our comprehensive approach goes beyond a single asset or portfolio, looking at four major areas of focus — strategy, process, technology and sourcing — to deliver actionable insights and solutions that are transformative to the organization.
Most importantly, we have a firm belief in being a trusted partner to our customers, establishing long-standing relationships with an independent mindset and dedication to developing solutions with only their best interests in mind.